SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-020590
Filing Date
2024-06-18
Accepted
2024-06-18 08:05:13
Documents
20
Period of Report
2024-06-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K aytu20240607c_8k.htm   iXBRL 8-K 31836
2 EXHIBIT 10.1 ex_688588.htm EX-10.1 918396
3 EXHIBIT 10.2 ex_688889.htm EX-10.2 21117
4 EXHIBIT 10.3 ex_688888.htm EX-10.3 30206
5 EXHIBIT 99.1 ex_685606.htm EX-99.1 15873
10 logo01.jpg GRAPHIC 3651
11 logo.jpg GRAPHIC 4381
  Complete submission text file 0001437749-24-020590.txt   1369719

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA aytu-20240612.xsd EX-101.SCH 3409
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aytu-20240612_def.xml EX-101.DEF 11807
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE aytu-20240612_lab.xml EX-101.LAB 15858
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aytu-20240612_pre.xml EX-101.PRE 12022
23 EXTRACTED XBRL INSTANCE DOCUMENT aytu20240607c_8k_htm.xml XML 2940
Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 241050231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)